Phase II Study of Venetoclax Added to Cladribine Plus Low-Dose Cytarabine Alternating With 5-Azacitidine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia

Kadia, Tapan M ; Reville, Patrick K ; Wang, Xuemei ; Rausch, Caitlin R ; Borthakur, Gautam ; Pemmaraju, Naveen ; Daver, Naval G ; DiNardo, Courtney D ; Sasaki, Koji ; Issa, Ghayas C ; Ohanian, Maro ; Montalban-Bravo, Guillermo ; Short, Nicholas J ; Jain, Nitin ; Ferrajoli, Alessandra ; Bhalla, Kapil N ; Jabbour, Elias ; Takahashi, Koichi ; Malla, Rashmi ; Quagliato, Kelly ; Kanagal-Shamanna, Rashmi ; Popat, Uday R ; Andreeff, Michael ; Garcia-Manero, Guillermo ; Konopleva, Marina Y ; Ravandi, Farhad ; Kantarjian, Hagop M

United States

Texto completo disponível

Activity of venetoclax-based therapy in TP53 -mutated acute myeloid leukemia

Shoukier, Mahran ; Konopleva, Marina ; Dinardo, Courtney Denton ; Ravandi, Farhad ; Andreeff, Michael ; Garcia-Manero, Guillermo ; Jabbour, Elias ; Daver, Naval Guastad ; Borthakur, Gautam ; Pemmaraju, Naveen ; Montalban-Bravo, Guillermo ; Benton, Christopher Brent ; Short, Nicholas James ; Bhalla, Kapil N. ; Cortes, Jorge E. ; Kantarjian, Hagop M. ; Kadia, Tapan M.

Texto completo disponível

Clinical observations of AML expressing mutant RUNX1 and pre-clinical studies of RUNX1-targeted novel therapy of AML

Dinardo, Courtney Denton ; Mill, Christopher P ; Fiskus, Warren ; Saenz, Dyana T ; Nowak, Agnieszka J ; Sun, Baohua ; Patel, Keyur ; Kadia, Tapan M. ; Benton, Christopher Brent ; Takahashi, Koichi ; Kantarjian, Hagop M. ; Bhalla, Kapil N.

Texto completo disponível

Phase I-II study of the histone deacetytase inhibitor vorinostat plus sequential weekly paclitaxel and doxorubicin-cyclophosphamide in locally advanced breast cancer

Tu, Yifan ; Hershman, Dawn L. ; Pellegrino, Christine M. ; Andreopoulou, Eleni ; Makower, Della ; Fineberg, Susan ; Bhalla, Kapil N. ; Kalinsky, Kevin ; Fehn, Karen ; Huang, Min ; Alpaugh, R. Katherine ; Sparano, Joseph A.

Texto completo disponível

Retrospective analysis and chemotherapy results in extra-nodal NHL patients in a large super-speciality hospital in North India

Aggarwal, S. ; Prakhar, P. ; Kohli, S. ; Negi, A. ; Jauhari, M. ; Bhalla, S.

Texto completo disponível

A phase Ib study of oral panobinostat (LBH589) administered with 5-azacitidine (5-Aza) in patients with myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML), or acute myeloid leukemia (AML)

Ottmann, O. G. ; Fenaux, P. ; Lübbert, M. ; DeAngelo, D. J. ; Garcia-Manero, G. ; Bhalla, K. N. ; Sekeres, M. A. ; Lüdicke, F. ; Weber, H. J. ; Winiger, I. J.

Texto completo disponível

A phase II trial of oral panobinostat (LBH589), a novel deacetylase inhibitor (DACi) in patients with primary myelofibrosis (PMF), post-essential thrombocythemia (ET) myelofibrosis, and post-polycythemia vera (PV) myelofibrosis

DeAngelo, D. J. ; Tefferi, A. ; Mesa, R. A. ; Paley, C. S. ; Wadleigh, M. ; Snyder, D. ; Ondovik, M. S. ; Rine, J. ; Bhalla, K. N.

Texto completo disponível

Health state utility and toxicities in metastatic lung and breast cancer: A qualitative study

Bhalla, S. ; Nafees, B. ; Stafford, M. ; Watkins, J.

Sem texto completo

Health state utility and toxicities in metastatic lung cancer: A qualitative study

Nafees, B. ; Stafford, M. ; Bhalla, S. ; Watkins, J.

Sem texto completo

A phase I dose escalation study of AUY922, a novel HSP90 inhibitor, in patients with advanced solid malignancies

Sessa, C. ; Sharma, S. K. ; Britten, C. D. ; Vogelzang, N. J. ; Bhalla, K. N. ; Mita, M. M. ; Pluard, T. J. ; Stiegler, P. ; Quadt, C. ; Shapiro, G. I.

Texto completo disponível